Literature DB >> 23347350

Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.

J Charles Jennette1, Ronald J Falk, Peiqi Hu, Hong Xiao.   

Abstract

Clinical, in vitro, and experimental animal observations indicate that antineutrophil cytoplasmic autoantibodies (ANCA) are pathogenic. The genesis of the ANCA autoimmune response is a multifactorial process that includes genetic predisposition, environmental adjuvant factors, an initiating antigen, and failure of T cell regulation. ANCA activate primed neutrophils (and monocytes) by binding to certain antigens expressed on the surface of neutrophils in specific inflammatory microenvironments. ANCA-activated neutrophils activate the alternative complement pathway, establishing an inflammatory amplification loop. The acute injury elicits an innate inflammatory response that recruits monocytes and T lymphocytes, which replace the neutrophils that have undergone karyorrhexis during acute inflammation. Extravascular granulomatous inflammation may be initiated by ANCA-induced activation of extravascular neutrophils, causing tissue necrosis and fibrin formation, which would elicit an influx of monocytes that transform into macrophages and multinucleated giant cells. Over time, the neutrophil-rich acute necrotizing lesions cause the accumulation of more lymphocytes, monocytes, and macrophages and produce typical granulomatous inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23347350      PMCID: PMC5507606          DOI: 10.1146/annurev-pathol-011811-132453

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  86 in total

Review 1.  Complement in ischemia reperfusion injury.

Authors:  Niels C Riedemann; Peter A Ward
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

2.  Silica and asbestos exposure in ANCA-associated vasculitis with pulmonary involvement.

Authors:  Zuzana Rihova; Dita Maixnerova; Eva Jancova; Daniela Pelclova; Jirina Bartunkova; Zdenka Fenclova; Zdenka Vankova; Jana Reiterova; Miroslav Merta; Romana Rysava; Vladimir Tesar
Journal:  Ren Fail       Date:  2005       Impact factor: 2.606

Review 3.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

4.  Toll-like receptor 2 induces Th17 myeloperoxidase autoimmunity while Toll-like receptor 9 drives Th1 autoimmunity in murine vasculitis.

Authors:  Shaun A Summers; Oliver M Steinmetz; Poh-Yi Gan; Joshua D Ooi; Dragana Odobasic; A Richard Kitching; Stephen R Holdsworth
Journal:  Arthritis Rheum       Date:  2011-04

5.  Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.

Authors:  Amanda-Jane Ruth; A Richard Kitching; Rain Y Q Kwan; Dragana Odobasic; Joshua D K Ooi; Jennifer R Timoshanko; Michael J Hickey; Stephen R Holdsworth
Journal:  J Am Soc Nephrol       Date:  2006-06-12       Impact factor: 10.121

6.  The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies.

Authors:  Hong Xiao; Peter Heeringa; Zhi Liu; Dennis Huugen; Peiqi Hu; Nobuyo Maeda; Ronald J Falk; J Charles Jennette
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

7.  Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.

Authors:  R J Falk; R S Terrell; L A Charles; J C Jennette
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

8.  Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis.

Authors:  J C Jennette; A S Wilkman; R J Falk
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

Review 9.  Antigenic complementarity in the induction of autoimmunity: a general theory and review.

Authors:  Robert Root-Bernstein
Journal:  Autoimmun Rev       Date:  2006-10-11       Impact factor: 9.754

10.  Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis.

Authors:  Estela Nogueira; Sally Hamour; Devika Sawant; Scott Henderson; Nicholas Mansfield; Konstantia-Maria Chavele; Charles D Pusey; Alan D Salama
Journal:  Nephrol Dial Transplant       Date:  2010-01-25       Impact factor: 5.992

View more
  99 in total

Review 1.  Innate immune cells in the pathogenesis of primary systemic vasculitis.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2015-09-24       Impact factor: 2.631

2.  Antineutrophil cytoplasm antibody-positive pulmonary-renal syndrome in a patient with diffuse cutaneous systemic sclerosis.

Authors:  Lennart Tonneijck; Anisha Tanna; Charles D Pusey
Journal:  BMJ Case Rep       Date:  2013-06-13

3.  Susceptibility quantitative trait loci for pathogenic leucocytosis in SCG/Kj mice, a spontaneously occurring crescentic glomerulonephritis and vasculitis model.

Authors:  Y Hamano; M Abe; S Matsuoka; D Zhang; Y Kondo; Y Kagami; A Ishigami; N Maruyama; Y Tsuruta; W Yumura; K Suzuki
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

4.  Autoantibodies to hLAMP-2 in ANCA-negative pauci-immune focal necrotizing GN.

Authors:  Andrea Peschel; Neil Basu; Alexandra Benharkou; Ricarda Brandes; Markus Brown; Andrew J Rees; Renate Kain
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

5.  Neutrophil extracellular trap formation is associated with autophagy-related signalling in ANCA-associated vasculitis.

Authors:  S Tang; Y Zhang; S-W Yin; X-J Gao; W-W Shi; Y Wang; X Huang; L Wang; L-Y Zou; J-H Zhao; Y-J Huang; L-Y Shan; A S Gounni; Y-Z Wu; J-B Zhang
Journal:  Clin Exp Immunol       Date:  2015-04-29       Impact factor: 4.330

6.  C5a receptor (CD88) blockade protects against MPO-ANCA GN.

Authors:  Hong Xiao; Daniel J Dairaghi; Jay P Powers; Linda S Ertl; Trageen Baumgart; Yu Wang; Lisa C Seitz; Mark E T Penfold; Lin Gan; Peiqi Hu; Bao Lu; Norma P Gerard; Craig Gerard; Thomas J Schall; Juan C Jaen; Ronald J Falk; J Charles Jennette
Journal:  J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 10.121

7.  A myelopoiesis gene signature during remission in anti-neutrophil cytoplasm antibody-associated vasculitis does not predict relapses but seems to reflect ongoing prednisolone therapy.

Authors:  T Kurz; M Weiner; C Skoglund; S Basnet; P Eriksson; M Segelmark
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

8.  CD14 expression is increased on monocytes in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis and correlates with the expression of ANCA autoantigens.

Authors:  R M Tarzi; J Liu; S Schneiter; N R Hill; T H Page; H T Cook; C D Pusey; K J Woollard
Journal:  Clin Exp Immunol       Date:  2015-07       Impact factor: 4.330

Review 9.  Vasculitis: do we know more to classify better?

Authors:  Ezgi Deniz Batu; Seza Ozen
Journal:  Pediatr Nephrol       Date:  2014-12-06       Impact factor: 3.714

10.  Circulating C3 levels predict renal and global outcome in patients with renal vasculitis.

Authors:  Javier Villacorta; Francisco Diaz-Crespo; Mercedes Acevedo; Teresa Cavero; Carmen Guerrero; Manuel Praga; Gema Fernandez-Juarez
Journal:  Clin Rheumatol       Date:  2016-08-25       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.